Cancer Institute and Hospital Chinese Academy of Medical Sciences
Welcome,         Profile    Billing    Logout  
 12 Trials 
12 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Qing
NCT04218487: Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)

Recruiting
4
720
RoW
Xuefu-Zhuyu Capsule, placebo, conventional therapy
Zhong Wang
Chinese Medicine, Stable Coronary Heart Disease, Chronic Insomnia, Headache, Endometriosis
12/23
06/24
NCT04263922: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3

Recruiting
4
466
RoW
Huaiqihuang granules, B12000050755, Valsartan capsule, H20030638
The First Affiliated Hospital of Dalian Medical University, Huazhong University of Science and Technology, LinkDoc Technology (Beijing) Co. Ltd.
Renal Insufficiency, Chronic
10/25
03/26
NCT06264778: Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma

Not yet recruiting
3
10
NA
Dabrafenib, fenestration decompression
Shandong University
Ameloblastoma
11/25
12/25
NCT06329908: DC Combined With ICIs in the Treatment of Advanced Lung Cancer Resistant to ICIs

Recruiting
1
20
RoW
LG002, ICIs
Zhen-Yu Ding
Lung Cancer
09/24
10/26
NCT05001659: The Comparison of the Two Simulators for ACLS Training

Recruiting
N/A
10
RoW
computer simulator and mannequin simulator
Tianjin Medical University General Hospital
Computer Simulator and Mannequin Simulator
12/21
12/21
NCT06434987: Impact of RIVP on GI Function in Patients Undergoing Surgical Repair for ATAAD

Recruiting
N/A
30
RoW
Retrograde Inferior Vena Cava Perfusion, Antegrade cerebral perfusion
The Second Hospital of Nanjing Medical University
Type A Aortic Dissection
08/24
08/24
NCT05782881: High Risk Population of Cardiovascular Disease in Hubei Province Screening and Intervention Program

Recruiting
N/A
16000
RoW
phone calls and encouraging patients' lifestyle change and medication adherence, Statin, Angiotensin-converting enzyme inhibitor, Angiotensin receptor neprilysin inhibitor, Glucagon-like peptide-1, Sodium-dependent glucose transporters 2
Wuhan Union Hospital, China, Peking University First Hospital
Cardiovascular Diseases, Diabetes Mellitus, Type 2, Coronary Disease
12/23
12/24
NCT05606848: To Test the Food for Special Medical Purpose in Perioperative Patients With Gastrointestinal Cancer

Recruiting
N/A
350
RoW
Nutrition Emulsion (TPF-T), Foods for special medical purposes [FSMP] for patients with tumors
Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd
Gastrointestinal Cancer
03/25
03/25
NCT05051852: HPV Viral Load in Predicting the Prognosis of LSIL

Recruiting
N/A
1000
RoW
Follow up
Fujian Maternity and Child Health Hospital
HPV Infection, LSIL, Low-Grade Squamous Intraepithelial Lesions, Viral Load
12/24
12/24
NCT05282095: Effect of HPV Integration on Prognosis of Young Women With CIN2 in China

Recruiting
N/A
300
RoW
Follow up
Fujian Maternity and Child Health Hospital
Cervical Intraepithelial Neoplasia, HPV Infection, Virus Integration, HSIL, High Grade Squamous Intraepithelial Lesions
12/25
05/26
NCT05282745: A Multicenter Cohort Study of HPV Viral Load in Predicting the Postoperative Recurrence of HSIL

Recruiting
N/A
4000
RoW
Follow-up
Fujian Maternity and Child Health Hospital
HPV Infection, HSIL, High-Grade Squamous Intraepithelial Lesions, Viral Load
12/24
12/24
NCT05283239: Research About Impact of HPV Integration on the Prognosis of Women With Persistent HR-HPV Infection

Recruiting
N/A
1000
RoW
Follow up
Fujian Maternity and Child Health Hospital
HPV Infection, LSIL, Low-Grade Squamous Intraepithelial Lesions, HSIL, High-Grade Squamous Intraepithelial Lesions, Virus Integration
11/24
12/24
Wang, Jinwan
No trials found
Ma, Jianhui
No trials found
Zhong, Dafang
No trials found

Download Options